Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2017

View Archived Issues

Celgene agrees to acquire Delinia

Gene therapy GS-030 receives U.S. orphan status for retinitis pigmentosa

New trial will explore 5-ALA to prevent reduction in cardiac output after heart bypass surgery

Therapicon's melatonin formulation named U.S. orphan drug for necrotizing enterocolitis

Topline results from two pivotal phase III trials of SB-204 in patients with acne vulgaris

Ramot and Merck collaborate to develop antibody-drug conjugates for cancer

EMA's CHMP supports approval of Revlimid for post-ASCT maintenance therapy in MM

EMA committee gives positive opinion for Pfizer's Xeljanz

GreenPeptide initiates phase II trial of GRN-1201 for NSCLC in U.S.

Biogen presents promising data for the novel radiotracer MK-6240

Recordati's Cystadrops approved in E.U.

Scancell and Addario Lung Cancer Medical Institute collaborate on trials of SCIB-2

Phase Ib results for oral CC-122 in patients with advanced hepatocellular carcinoma

FDA approves Latuda to treat schizophrenia in adolescents

Amgen receives positive opinion for biosimilar adalimumab ABP-501

FDA maintains clinical hold on Regulus' RG-101 program

Topline results from phase III chronic constipation trial of linaclotide in Japan

GlaxoSmithKline discovers novel BMP-1 and TLL1/2 inhibitors

Sage Therapeutics presents new NMDA receptor ligands

Piramal Enterprises to acquire intrathecal spasticity and pain management drugs from Mallinckrodt

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Research Council of Norway grant supports Bionor's development of Vacc-4x for HIV

Losartan given with FOLFIRINOX in phase II trial in locally advanced pancreatic cancer

Results from phase Ib trial of AM-0010 plus FOLFOX in metastatic pancreatic adenocarcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...